REFERENCES
1. Labiris NR, Dolovich MB. Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in
therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol 2003;56(6):600-612.
2. Dolovich MB, Ahrens RC, Hess DR, et al. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American
College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest 2005;127(1):335-371.
3. Dano G. Bronchospasm caused by acetylcysteine in children with bronchial asthma. Acta Allergol 1971;26(3):181-190.
4. Conway SP. Nebulized antibiotic therapy: the evidence. Chron Respir Dis 2005;2(1):35-41.
5. Reinero CR, Delgado C, Spinka C, et al. Enantiomer-specific effects of albuterol on airway inflammation in healthy and asthmatic
cats. Int Arch Allergy Immunol 2009;150(1):43-50.
6. Bemis DA, Appel MJG. Aerosol, parenteral, and oral antibiotic treatment of Bordetella bronchiseptica infections in dogs. J Am Vet Med Assoc 1977;170(10):1082-1086.
7. Riviere JE, Silver GR, Coppoc GL, et al. Gentamicin aerosol therapy in 18 dogs: failure to induce detectable serum concentrations
of the drug. J Am Vet Med Assoc 1981;179(2):166-168.
8. Miller CJM, McKiernan BC, Hauser C, et al. Gentamicin aerosolization for the treatment of infectious tracheobronchitis (abst).
J Vet Intern Med 2003;17:386.
9. Schulman RL, Crochik SS, Kneller SK, et al. Investigation of pulmonary deposition of a nebulized radiopharmaceutical agent
in awake cats. Am J Vet Res 2004;65(6):806-809.
10. Reinero CR, Decile KC, Byerly JR, et al. Effects of drug treatment on inflammation and hyperreactivity of airways and on
immune variables in cats with experimentally induced asthma. Am J Vet Res 2005;66(7):1121-1127.
11. Kirschvink N, Leemans J, Delvaux F, et al. Inhaled fluticasone reduces bronchial responsiveness and airway inflammation in
cats with mild chronic bronchitis. J Feline Med Surg 2006;8(1):45-54.
12. Cohn LA, DeClue AE, Cohen RL, et al. Dose effects of fluticasone propionate in an experimental model of feline asthma (abst).
J Vet Intern Med 2008;22(3):706.
13. Bexfield NH, Foale RD, Davison LJ, et al. Management of 13 cases of canine respiratory disease using inhaled corticosteroids.
J Small Anim Pract 2006;47(7):377-382.
14. Cohn LA, DeClue AE, Reinero CR. Endocrine and immunologic effects of inhaled fluticasone propionate in healthy dogs. J Vet Intern Med 2008;22(1):37-43.
15. Reinero CR, Brownlee L, Decile KC, et al. Inhaled flunisolide suppresses the hypothalamic-pituitary-adrenocortical axis,
but has minimal systemic immune effects in healthy cats. J Vet Intern Med 2006;20(1):57-64.
16. Kirschvink N, Leemans J, Delvaux F, et al. Bronchodilators in bronchoscopy-induced airflow limitation in allergen-sensitized
cats. J Vet Intern Med 2005;19(2):161-167.
17. Hershey AE, Kurzman ID, Forrest LJ, et al. Inhalation chemotherapy for macroscopic primary or metastatic lung tumors: proof
of principle using dogs with spontaneously occurring tumors as a model. Clin Cancer Res 1999;5(9):2653-2659.
18. Selting K, Waldrep JC, Reinero C, et al. Feasibility and safety of targeted cisplatin delivery to a select lung lobe in dogs
via the AeroProbe intracorporeal nebulization catheter. J Aerosol Med Pulm Drug Deliv 2008;21(3):255-268.
19. Khanna C, Anderson PM, Hasz DE, et al. Interleukin-2 liposome inhalation therapy is safe and effective for dogs with spontaneous
pulmonary metastases. Cancer 1997;79(7):1409-1421.
20. Cherrington AD, Neal DW, Edgerton DS, et al. Inhalation of insulin in dogs: assessment of insulin levels and comparison to
subcutaneous injection. Diabetes 2004;53(4):877-881.
21. DeClue AE, Leverenz EF, Wiedmeyer CE, et al. Glucose lowering effects of inhaled insulin in healthy cats. J Feline Med Surg 2008;10(5):519-522.
22. Laube BL. The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination. Respir Care 2005;50(9):1161-1176.
|
Featuring Information from:
